Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Marksans Pharma Ltd.
NSE: MARKSANS
|
BSE: 524404
|
ISIN: INE750C01026
|
Industry: Pharmaceuticals
US FDA Approval
|
Mid-range Performer
168.1500
0.11
(
0.07
%)
NSE
Apr 02, 2026
15:31 PM
New 52W Low in past week
Volume:
550.7K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Marksans Pharma Ltd.
14 Mar 2024
US FDA Approval
168.15
0.07%
MARKSANS PHARMA LTD.
Buy:
Marksans Pharma Ltd.
by
Ventura
Target: 301
Target
Ventura
Growth in demand and capabilities
Institutional Investors have decreased holdings from 22.20% to 14.04% in Dec 2025 qtr
More from Marksans Pharma Ltd.
Recommended
Five Interesting Stocks Today - April 2, 2026
The Baseline |
02 Apr 2026, 06:00PM
Market closes higher on strong rupee and value buying
Trendlyne Marketwatch |
02 Apr 2026, 03:59PM
Marksans Pharma facility receives four observations from US FDA
|
10 Apr 2017